Cargando…
Isolation, Identification, and Characterization of an Unknown Impurity in Lovastatin EP
An unknown impurity in the fermentation-based drug substance lovastatin at 0.52 RRT was observed invariably in all batches when analyzed by HPLC as per the PhEur monograph. This impurity was isolated from the impurity-enriched sample using reversed-phase preparative HPLC and characterized by using s...
Autores principales: | Belwal, Chandrakant, Goyal, Praveen Kumar, Balte, Anup, Kolhe, Sandeep, Chauhan, Kamlesh, Rawat, Ajay Singh, Vardhan, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951232/ https://www.ncbi.nlm.nih.gov/pubmed/24634841 http://dx.doi.org/10.3797/scipharm.1305-04 |
Ejemplares similares
-
Identification, Isolation and Characterization of an Unknown Impurity of Varenicline
por: Satheesh, Balasubramanian, et al.
Publicado: (2012) -
Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method
por: Xu, Ao, et al.
Publicado: (2023) -
Gold and platinum in silicon-isolated impurities and impurity complexes
por: Burchard, A, et al.
Publicado: (1996) -
Gold and platinum in silicon isolated impurities and impurity complexes
por: Burchard, A, et al.
Publicado: (1996) -
Improved bioavailability through floating microspheres of lovastatin
por: Kumar, S., et al.
Publicado: (2011)